|  | Early stage cases (stage I & II, n = 88) | Advanced stage cases (stage III & IV, n = 159) | ||||
---|---|---|---|---|---|---|---|
 |  | YY1 nuclear expression | YY1 nuclear expression | ||||
 |  | Negative/weak | Strong | p- value | Negative/weak | Strong | p-value |
 |  | Number (%) | Number (%) |  | Number (%) | Number (%) |  |
Sex | M | 12 (20.3) | 47 (79.7) | 0.969 | 56 (52.3) | 51 (47.7) | 0.961 |
 | F | 6 (20.7) | 23 (79.3) |  | 27 (51.9) | 25 (48.1) |  |
Age | <=60 | 6 (20.7) | 23 (79.3) | 0.969 | 39 (61.9) | 24 (38.1) | 0.053 |
 | >60 | 12 (20.3) | 47 (79.7) |  | 44 (45.8) | 52 (54.2) |  |
Type | Intestinal | 17 (26.2) | 48 (73.8) | 0.031 | 47 (61.8) | 29 (38.2) | 0.020 |
 | Diffuse | 1 (4.5) | 21 (95.5) |  | 36 (43.4) | 47 (56.6) |  |
Grade | 1 | 2 (28.6) | 5 (79.7) | 0.866 | 1 (100.0) | 0 (0.0) | 0.033 |
 | 2 | 8 (20.0) | 32 (80.0) |  | 38 (64.4) | 21 (35.6) |  |
 | 3 | 8 (20.0) | 32 (80.0) |  | 44 (44.4) | 55 (55.6) |  |
Stage (T) | 1 | 7 (21.2) | 26 (78.8) | 0.909 | 1 (50.0) | 1 (50.0) | 0.971 |
 | 2 | 10 (21.3) | 37 (78.7) |  | 13 (52.0) | 12 (48.0) |  |
 | 3 | 1 (14.3) | 6 (85.7) |  | 65 (52.8) | 58 (47.2) |  |
 | 4 |  |  |  | 4 (44.4) | 5 (55.6) |  |
Stage (N) | 0 | 13 (23.6) | 42 (76.4) | 0.623 | 1 (50.0) | 1 (50.0) | 0.841 |
 | 1 | 5 (16.1) | 26 (83.9) |  | 17 (53.1) | 15 (46.9) |  |
 | 2 | 0 (0.0) | 1 (100.0) |  | 36 (48.6) | 38 (51.4) |  |
 | 3 |  |  |  | 29 (56.9) | 22 (43.1) |  |
Stage (M) | 0 | 18 (20.5) | 70 (79.5) | Â | 64 (52.0) | 59 (48.0) | 0.937 |
 | 1 |  |  |  | 19 (52.8) | 17 (47.2) |  |
Lymph Node | 0 | 13 (23.6) | 42 (76.4) | 0.374 | 1 (50.0) | 1 (50.0) | 0.950 |
 | 1 | 5 (15.6) | 27 (84.4) |  | 82 (52.2) | 75 (47.8) |  |
H. pylori | Absence | 7 (18.4) | 31 (81.6) | 0.743 | 36 (47.4) | 40 (52.6) | 0.417 |
 | Presence | 10 (21.3) | 37 (78.7) |  | 41 (53.9) | 35 (46.1) |  |